Advances in Cancer Therapy

Kalorama Information
February 1, 2001
394 Pages - SKU: KLI25
The World Market for Flow Cytometry in IVD Applications
6/16/2014 | published by: Kalorama Information
The World Market for Flow Cytometry in IVD Applications Flow cytometers are powerful reference lab instruments that are now an important component of advanced IVD labs in developed nations. They are advanced diagnostic  |  read more...
USD 1,995
Proteins in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
Proteins in Oncology Drug Pipeline Update 2014 This drug pipeline update covers proteins, excluding antibodies, as drugs for the treatment of cancer. There are today 326 companies plus partners developing 359 protein drugs in 667 developmental projects  |  read more...
USD 6,746
Malignant Mesothelioma - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
Malignant Mesothelioma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Malignant Mesothelioma - Pipeline Review, H2 2014’, provides an overview of the Malignant Mesothelioma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Malignant  |  read more...
USD 2,000
IL-7 Signaling Pathway in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
IL-7 Signaling Pathway in Oncology Drug Pipeline Update 2014 IL-7 signaling pathway mainly activates the JAK/STAT signaling module. There are today 66 companies plus partners developing 72 IL-7 pathway targeting drugs in 299 developmental projects in cancer.  |  read more...
USD 2,246
RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update 2014 Potentially any disease-causing gene, cell type or tissue can be targeted with miRNA, RNAi or siRNA, including those not ’druggable’ with small molecules or  |  read more...
USD 4,496
T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2014 Stimulation of the T cell receptor leads to the activation of NFkB and NFAT signaling modules which play a key role in T cell receptor  |  read more...
USD 6,746
EGFR1 Signaling Pathway in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
EGFR1 Signaling Pathway in Oncology Drug Pipeline Update 2014 The EGFR1 signaling pathway activates the Ras/Raf/MAPK signaling modules. There are today 371 companies plus partners developing 642 EGFR1 pathway targeting drugs in 2397 developmental projects in cancer.  |  read more...
USD 6,746
IL-9 Signaling Pathway in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
IL-9 Signaling Pathway in Oncology Drug Pipeline Update 2014 The IL-9 signaling pathway activates Jak/STAT and MAPK signaling modules. There are today 63 companies plus partners developing 67 IL-9 pathway targeting drugs in 275 developmental projects in  |  read more...
USD 4,496
Immunotherapy in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
Immunotherapy in Oncology Drug Pipeline Update 2014 Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug Pipeline Update BioSeeker brings together the fields of antibodies,  |  read more...
USD 11,025
Radiation Therapy in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
Radiation Therapy in Oncology Drug Pipeline Update 2014 This drug pipeline update is structured around radiolabeled drugs, radiosensitizers and radioprotective compounds. There are today 318 companies plus partners developing 333 radiation therapy drugs in 725 developmental projects  |  read more...
USD 6,746
 

SELECT A LICENSE

    Online Download  USD 350  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!